Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
- PMID: 37766089
- PMCID: PMC10537287
- DOI: 10.3390/vaccines11091412
Efficacy and Safety of Vaccinations in Geriatric Patients: A Literature Review
Abstract
With the progressive lengthening of the average age of the population, especially in some countries such as Italy, vaccination of the elderly is a fixed point on which most of the public health efforts are concentrating as epidemic infectious diseases, especially those of the winter, have a major impact on the progression of severe disease, hospitalization, and death. The protection of the elderly against acute infectious diseases should not only limit mortality but also have a positive impact on the fragility of these people in terms of less disability and fewer care needs. However, vaccination of the elderly population differs in efficacy and safety compared to that of other population categories since aging and the consequent loss of efficiency of the immune system lead to a reduction in the immunogenicity of vaccines without achieving a lasting antibody coverage. There are various strategies to avoid the failure of immunization by vaccines such as resorting to supplementary doses with adjuvant vaccines, increasing the dosage of the antigen used, or choosing to inoculate the serum relying on various routes of administration of the vaccine. Vaccination in the elderly is also an important factor in light of growing antibiotic resistance because it can indirectly contribute to combating antibiotic resistance, reducing theoretically the use of those agents. Furthermore, vaccination in old age reduces mortality from infectious diseases preventable with vaccines and reduces the same rate of resistance to antibiotics. Given the importance and complexity of the topic, in this review, we will deal with the main aspects of vaccination in the elderly and how it can influence mortality and healthcare costs, especially in those countries where population aging is more evident. Therefore, we conducted a systematic literature search in PubMed to identify all types of studies published up to 31 May 2023 that examined the association between vaccination and the elderly. Data extraction and quality assessment were conducted by two reviewers (PC and TC) who independently extracted the following data and assessed the quality of each study.
Keywords: efficacy; elderly; health problem; safety; vaccination.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Needle size for vaccination procedures in children and adolescents.Cochrane Database Syst Rev. 2018 Aug 9;8(8):CD010720. doi: 10.1002/14651858.CD010720.pub3. Cochrane Database Syst Rev. 2018. PMID: 30091147 Free PMC article.
-
[A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].Ann Ig. 2013 Jan-Feb;25(1):43-56. doi: 10.7416/ai.2013.1905. Ann Ig. 2013. PMID: 23435779 Italian.
-
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 15;21(1):853. doi: 10.1186/s13063-020-04775-4. Trials. 2020. PMID: 33059771 Free PMC article. Clinical Trial.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis.Viruses. 2022 Nov 3;14(11):2438. doi: 10.3390/v14112438. Viruses. 2022. PMID: 36366536 Free PMC article. Review.
Cited by
-
The desire of autonomy: A lever for vaccination of the elderly? Results of a qualitative study.Hum Vaccin Immunother. 2024 Dec 31;20(1):2390227. doi: 10.1080/21645515.2024.2390227. Epub 2024 Aug 19. Hum Vaccin Immunother. 2024. PMID: 39161121 Free PMC article.
-
Improving Vaccine Coverage Among Older Adults and High-Risk Patients: A Systematic Review and Meta-Analysis of Hospital-Based Strategies.Healthcare (Basel). 2025 Jul 10;13(14):1667. doi: 10.3390/healthcare13141667. Healthcare (Basel). 2025. PMID: 40724691 Free PMC article. Review.
-
Comparative immune response of Typbar TCV® (typhoid conjugate vaccine) in extremes of age: An Indian experience.Hum Vaccin Immunother. 2025 Dec;21(1):2507912. doi: 10.1080/21645515.2025.2507912. Epub 2025 May 30. Hum Vaccin Immunother. 2025. PMID: 40445123 Free PMC article. Clinical Trial.
-
Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection.NPJ Vaccines. 2024 Feb 20;9(1):37. doi: 10.1038/s41541-024-00817-z. NPJ Vaccines. 2024. PMID: 38378953 Free PMC article.
-
Enhancing vaccine effectiveness in the elderly to counter antibiotic resistance: The potential of adjuvants via pattern recognition receptors.Hum Vaccin Immunother. 2024 Dec 31;20(1):2317439. doi: 10.1080/21645515.2024.2317439. Epub 2024 Mar 4. Hum Vaccin Immunother. 2024. PMID: 39693178 Free PMC article. Review.
References
-
- Aiello A., Ligotti M.E., Garnica M., Accardi G., Calabrò A., Pojero P., Arasanz H., Bocanegra A., Blanco E., Chocarro L., et al. How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. Int. J. Mol. Sci. 2022;23:9880. doi: 10.3390/ijms23179880. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources